Subscribe free

Newsletter

General Surgery

Best Papers in General Surgery

The five that matter, every day.

FreeNo spamOne-click unsubscribe
Langenbecks Arch Surg25 Nov 2023

CRP: Early Indicator of Anastomotic Leakage After Esophageal Cancer Surgery

In the world of esophageal cancer surgery, a study from Karolinska University Hospital unveils CRP (C-reactive protein) as a superhero. Analyzing 612 patients, the research identifies a spike of ≥4.65% in CRP levels between postoperative days 2 to 3 as a signal for anastomotic leakage…

J Clin Med25 Nov 2023

CT Staging Quirks: Unpacking the Nuances in Advanced Colon Tumor Diagnosis

In the quest for accurate preoperative staging of advanced colon tumors, the CT scan takes the stage. However, the spotlight reveals some hiccups. A national retrospective study with 1950 patients unfolded the CT's script, showing a 57% sensitivity in nailing T4 tumors, a 63% overall…

Ann Surg Open24 Nov 2023

Laparoscopy Packs Muscle Punch, Robotic Surgery Commands Cognitive Grit

In the epic battle of surgery techniques, researchers peek into surgeons' minds and muscles during live laparoscopic and robotic surgeries. Surprise twist: laparoscopy flexes more muscle power, especially in the right-side troops. Meanwhile, the robotic realm demands more brainpower, with greater cognitive stress observed. It's…

Appendix, Gallbladder and Surgical Emergencies24 Nov 2023

Unraveling Risks and Costs of Common Bile Duct Injury Post-Cholecystectomy in the U.S.

In the world of gallbladder adventures, a team unveils the secrets of common bile duct injury (CBDI) post-cholecystectomy in the U.S. Among 769,782 gallbladder enthusiasts, only 0.1% faced CBDI, linked to increased mortality risk. Biliary colic and obesity played guardian roles (lower risk), while pancreas…

Ann Surg Oncol24 Nov 2023

HIPEC Consensus: Dutch Protocol Prevails for Colorectal Cancer Peritoneal Metastases

Global Experts Agree: In treating colorectal cancer with peritoneal metastases, cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) extends median overall survival beyond 40 months. The consensus among 78% of international panelists highlights the conditionally recommended use of HIPEC post-surgery. The Dutch protocol, featuring mitomycin-C, gains…